| Issue Date | Title | Author(s) |
| 2017 | Burnout and cognitive impairment: Associated with serum BDNF in a Chinese Han population | He, S. C.; Zhang, Y. Y.; Zhan, J. Y.; Wang, C.; Du, X. D.; Yin, G. Z.; Cao, B.; Ning, Y. P.; Soares, J. C.; Zhang, X. Y. |
| 2019 | Changes in sleep quality as a predictor for response to vortioxetine in major depressive disorder | Cao, B.; Rosenblat, J.; Park, C.; Chen, Y.; Iacobucci, M.; Subramanieapillai, M.; Zuckerman, H.; McIntyre, R. |
| 2017 | Changing Trends In Antimicrobial Resistance And Serotype Distribution Of Streptococcus Pneumoniae Isolates In China From 2005 To 2014 | Zhao, C.; Zhang, F.; Chu, Y.; Cao, B.; Sun, H.; Yu, Y.; Liao, K.; Zhang, L.; Sun, Z.; Hu, B.; Lei, J.; Hu, Z.; Zhang, X.; Wang, H. |
| 2017 | Changing Trends In Antimicrobial Resistance And Serotype Distribution Of Streptococcus Pneumoniae Isolates In China From 2005 To 2014 | Zhao, C.; Zhang, F.; Chu, Y.; Cao, B.; Sun, H.; Yu, Y.; Liao, K.; Zhang, L.; Sun, Z.; Hu, B.; Lei, J.; Hu, Z.; Zhang, X.; Wang, H. |
| 2019 | Characterizing acyl-carnitine biosignatures for schizophrenia: a longitudinal pre- and post-treatment study | Cao, B.; Wang, D.; Pan, Z.; Brietzke, E.; McIntyre, R.; Wang, J. |
| 2018 | Clinical value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma (vol 8, pg 159, 2017) | Guo, Z.; Yi, F.; Yin, W.; Zhang, Y.; Li, Q.; Gu, Y.; Xiao, Y.; Cao, B.; Ma, L.; Liang, L. |
| 2019 | Comparison of serum alkali metals and alkaline-earth metals between patients with schizophrenia and healthy controls | Cao, B.; Chen, Y.; Yan, L.; McIntyre, R.; Wang, J. |
| 2019 | Correction: Glucose disturbances, cognitive deficits and white matter abnormalities in first-episode drug-naive schizophrenia (Molecular Psychiatry, (2019), 10.1038/s41380-019-0478-1) | Zhang, X.; Zhang, X.; Zhang, X.; Huang, X.; Wu, F.; Soares, J.C.; Cao, B.; Wang, L.; Chen, H.; Yang, M.; Yang, M.; Du, X.; Liao, W.; Chen, D.; Fan, F.; Xiu, M.; Jia, Q.; Ning, Y. |
| 2020 | Fangcang shelter hospitals in COVID-19 pandemic: the practice and its significance | Shang, L.; Xu, J.; Cao, B. |
| 2019 | Glucose disturbances, cognitive deficits and white matter abnormalities in first-episode drug-naive schizophrenia | Zhang, X.; Zhang, X.; Zhang, X.; Huang, X.; Wu, F.; Soares, J.C.; Cao, B.; Wang, L.; Chen, H.; Yang, M.; Yang, M.; Du, X.; Liao, W.; Chen, D.; Fan, F.; Xiu, M.; Jia, Q.; Ning, Y. |
| 2010 | Identification of serpinF2 as the early plasma biomarker for risk of severe preeclampsia | Li, D.; Wang, Y. L.; Huo, R.; Liao, Q. P.; Guo, X. J.; Sun, Y.; Wang, F. Q.; Wang, F. C.; Cao, B.; Yu, L.; Li, Y. X.; Wang, H. B.; Yang, H. X.; Sha, J. H. |
| 2019 | Metabolic profiling for water-soluble metabolites in patients with schizophrenia and healthy controls in a Chinese population: A case-control study | Cao, B.; Wang, D.; Pan, Z.; McIntyre, R.S.; McIntyre, R.S.; Brietzke, E.; Brietzke, E.; Subramanieapillai, M.; Nozari, Y.; Wang, J.; Wang, J.; Wang, J. |
| 2018 | Monolithic perovskite/Si tandem solar cells exceeding 22% efficiency via optimizing top cell absorber | Qiu, Z.; Xu, Z.; Li, N.; Zhou, N.; Chen, Y.; Wan, X.; Liu, J.; Li, N.; Hao, X.; Bi, P.; Chen, Q.; Cao, B.; Zhou, H. |
| 2019 | Parental characteristics and the risk of schizophrenia in a Chinese population: a case-control study | Cao, B.; Lu, Q.-B.; Lu, Q.-B.; Wang, D.-F.; Yan, L.-L.; Yan, L.-L.; Yan, L.-L.; McIntyre, R.S.; McIntyre, R.S.; Rosenblat, J.D.; Musial, N.; Liu, Y.-Q.; Xie, Q.; Wang, J.-Y.; Wang, J.-Y.; Wang, J.-Y. |
| Oct-2023 | Preliminary efficacy and safety of tinengotinib (TT-00420) monotherapy in Chinese patients (pts) with advanced solid tumors: Results from a phase Ib/II study | Zhang, P.; Gong, J.; Guo, H.; Han, W.; Cao, B.; Zhang, J.; Niu, Z.; Cheng, Y.; He, C.; Fan, J.; Peng, P.; Sun, C.; Wang, H.; Yu, Y.; Zhu, Y.; Wu, Y.; Li, Q.; Huang, P.; Wu, F.; Shen, L. |
| Apr-2021 | Primary results from the China cohort of IMpower132: Atezolizumab (atezo) plus carboplatin (carbo) or cisplatin (cis) plus pemetrexed (pem) as first-line therapy in advanced NSCLC | Lu, S.; Fang, J.; Wang, Z.; Fan, Y.; Liu, Y.; He, J.; Cao, B.; Zhou, J.; Hu, J.; Xia, J.; Liu, W.; Shi, J.; Yi, J.; Cao, L. |
| 2016 | Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections | Wang, Q.; Zhang, Y.; Yao, X.; Xian, H.; Liu, Y.; Li, H.; Chen, H.; Wang, X.; Wang, R.; Zhao, C.; Cao, B.; Wang, H. |
| 2019 | Synthetic control of Prussian blue derived nano-materials for energy storage and conversion application | Li, Y.; Hu, J.; Yang, K.; Cao, B.; Li, Z.; Yang, L.; Pan, F. |
| 2019 | Trace elements differences in the depression sensitive and resilient chronic unpredictable mild stress rat models | Cao, B.; Yan, L.; Chen, Y.; Wang, J. |
| 7-May-2020 | A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19 | Cao, B.; Wang, Y.; Wen, D.; Liu, W.; Wang, Jingli; Fan, G.; Ruan, L.; Song, B.; Cai, Y.; Wei, M.; Li, X.; Xia, J.; Chen, N.; Xiang, J.; Yu, T.; Bai, T.; Xie, X.; Zhang, L.; Li, C.; Yuan, Y.; Chen, H.; Li, Huadong; Huang, H.; Tu, S.; Gong, F.; Liu, Y.; Wei, Y.; Dong, C.; Zhou, F.; Gu, X.; Xu, J.; Liu, Z.; Zhang, Y.; Li, Hui; Shang, L.; Wang, K.; Li, K.; Zhou, X.; Dong, X.; Qu, Z.; Lu, S.; Hu, X.; Ruan, S.; Luo, S.; Wu, J.; Peng, L.; Cheng, F.; Pan, L.; Zou, J.; Jia, C.; Wang, Juan; Liu, X.; Wang, S.; Wu, X.; Ge, Q.; He, J.; Zhan, H.; Qiu, F.; Guo, L.; Huang, C.; Jaki, T.; Hayden, F. G.; Horby, P. W.; Zhang, D.; Wang, C. |
